Skip to content

Study · Non-randomized trial · n = 14 · 1999

12 results

Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease.

Arvat E, Ramunni J, Maccagno B, Giordano R, Broglio F, Deghenghi R, Boscaro M, Ghigo E

Neuroendocrinology1 Sept 1999Cited by 7 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study12

5 results from studies that gave the peptide. 5 results from people.

  1. 01HumanNon-randomized trialActivity measurement

    In patients with Addison's disease, hexarelin elicited a marked ACTH response that was higher than in normal subjects after hexarelin alone.

    In plain wordsIn people with Addison's disease, hexarelin caused a large ACTH rise, larger than in healthy people given hexarelin.

    Peptide
    Hexarelin
    Outcome
    IncreaseACTH response to hexarelin in Addison's disease versus normal subjects
    Study

    n = 14

    Comparator
    Normal subjects given hexarelin alone
    Outcome group
    Stress hormones · Endocrine and hormones
    Studied dose
    2.0 microgram/kg · intravenousAs given in this study (human).

    Source sentences

    Summary
    In AD, HEX elicited a marked ACTH response (6,619.4 +/- 3,365.8 pg/ml/h; p < 0.01), which was clearly higher (p < 0.01) than that in NS after HEX alone but not significantly different from that after HEX+MET.
    2 context sentences
    Summary · context
    The endocrine responses (mean +/- SEM) to HEX alone were also studied in 8 patients with Addison's disease (AD, 6 males, 2 females, age 30-77 years; last hydrocortisone administration the day before testing).
    Summary · context
    Based on the foregoing, we studied the ACTH, cortisol and GH responses to HEX (2.0 microgram/kg i.v. at 0 min) alone and after metyrapone (2 g p.o. at 23:00 h the night before) or RU-486 (400 mg p.o. at 02:00 h), a glucocorticoid receptor antagonist, in 6 normal women (NS, age 26-34 years).
  2. 02HumanNon-randomized trialActivity measurement

    In patients with Addison's disease, the GH response to hexarelin was similar to that in normal subjects.

    In plain wordsIn people with Addison's disease, growth hormone rose after hexarelin about as much as in healthy people.

    Peptide
    Hexarelin
    Outcome
    No significant changeGH response to hexarelin in Addison's disease versus normal subjects
    Study

    n = 14

    Comparator
    Normal subjects
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    2.0 microgram/kg · intravenousAs given in this study (human).

    Source sentences

    Summary
    The GH response to HEX in AD (1,325.6 +/- 284.1 microgram/l/h) was similar to that in NS (1,519.7 +/- 483.8 microgram/l/h).
    2 context sentences
    Summary · context
    The endocrine responses (mean +/- SEM) to HEX alone were also studied in 8 patients with Addison's disease (AD, 6 males, 2 females, age 30-77 years; last hydrocortisone administration the day before testing).
    Summary · context
    Based on the foregoing, we studied the ACTH, cortisol and GH responses to HEX (2.0 microgram/kg i.v. at 0 min) alone and after metyrapone (2 g p.o. at 23:00 h the night before) or RU-486 (400 mg p.o. at 02:00 h), a glucocorticoid receptor antagonist, in 6 normal women (NS, age 26-34 years).
  3. 03HumanNon-randomized trialActivity measurement

    In normal women, hexarelin increased ACTH levels over basal.

    In plain wordsIn healthy women, hexarelin raised ACTH levels above the starting level.

    Peptide
    Hexarelin
    Outcome
    IncreaseACTH response to hexarelin in normal women
    Study

    n = 6

    Comparator
    Basal levels
    Outcome group
    Stress hormones · Endocrine and hormones
    Studied dose
    2.0 microgram/kg · intravenousAs given in this study (human).

    Measurements

    Peak ACTH
    26 pg/ml
    hexarelin
    Basal ACTH
    10.7 pg/ml
    basal

    Source sentences

    Summary
    In NS, HEX stimulated basal ACTH (peak, mean +/- SEM: 26.0 +/- 7.8 vs. 10.7 +/- 2.0 pg/ml, p < 0. 05), cortisol (163.2 +/- 18.3 vs. 137.4 +/- 15.4 microgram/l, p < 0.05) and GH (72.6 +/- 23.5 vs. 3.7 +/- 1.3 microgram/l, p < 0.01) levels.
    1 context sentence
    Summary · context
    Based on the foregoing, we studied the ACTH, cortisol and GH responses to HEX (2.0 microgram/kg i.v. at 0 min) alone and after metyrapone (2 g p.o. at 23:00 h the night before) or RU-486 (400 mg p.o. at 02:00 h), a glucocorticoid receptor antagonist, in 6 normal women (NS, age 26-34 years).
  4. 04HumanNon-randomized trialActivity measurement

    In normal women, hexarelin increased cortisol levels over basal.

    In plain wordsIn healthy women, hexarelin raised cortisol levels above the starting level.

    Peptide
    Hexarelin
    Outcome
    IncreaseCortisol response to hexarelin in normal women
    Study

    n = 6

    Comparator
    Basal levels
    Outcome group
    Stress hormones · Endocrine and hormones
    Studied dose
    2.0 microgram/kg · intravenousAs given in this study (human).

    Measurements

    Peak cortisol
    163.2 microgram/l
    hexarelin
    Basal cortisol
    137.4 microgram/l
    basal

    Source sentences

    Summary
    In NS, HEX stimulated basal ACTH (peak, mean +/- SEM: 26.0 +/- 7.8 vs. 10.7 +/- 2.0 pg/ml, p < 0. 05), cortisol (163.2 +/- 18.3 vs. 137.4 +/- 15.4 microgram/l, p < 0.05) and GH (72.6 +/- 23.5 vs. 3.7 +/- 1.3 microgram/l, p < 0.01) levels.
    1 context sentence
    Summary · context
    Based on the foregoing, we studied the ACTH, cortisol and GH responses to HEX (2.0 microgram/kg i.v. at 0 min) alone and after metyrapone (2 g p.o. at 23:00 h the night before) or RU-486 (400 mg p.o. at 02:00 h), a glucocorticoid receptor antagonist, in 6 normal women (NS, age 26-34 years).
  5. 05HumanNon-randomized trialActivity measurement

    In normal women, hexarelin increased GH levels over basal.

    In plain wordsIn healthy women, hexarelin raised growth hormone levels above the starting level.

    Peptide
    Hexarelin
    Outcome
    IncreaseGH response to hexarelin in normal women
    Study

    n = 6

    Comparator
    Basal levels
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    2.0 microgram/kg · intravenousAs given in this study (human).

    Measurements

    Peak GH
    72.6 microgram/l
    hexarelin
    Basal GH
    3.7 microgram/l
    basal

    Source sentences

    Summary
    In NS, HEX stimulated basal ACTH (peak, mean +/- SEM: 26.0 +/- 7.8 vs. 10.7 +/- 2.0 pg/ml, p < 0. 05), cortisol (163.2 +/- 18.3 vs. 137.4 +/- 15.4 microgram/l, p < 0.05) and GH (72.6 +/- 23.5 vs. 3.7 +/- 1.3 microgram/l, p < 0.01) levels.
    1 context sentence
    Summary · context
    Based on the foregoing, we studied the ACTH, cortisol and GH responses to HEX (2.0 microgram/kg i.v. at 0 min) alone and after metyrapone (2 g p.o. at 23:00 h the night before) or RU-486 (400 mg p.o. at 02:00 h), a glucocorticoid receptor antagonist, in 6 normal women (NS, age 26-34 years).

Studies that did not test the peptide alone7

In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Hexarelin.

  1. 06HumanNot a test of Hexarelin aloneNon-randomized trialActivity measurement

    In patients with Addison's disease, the ACTH response to hexarelin did not differ significantly from that of normal subjects after hexarelin plus metyrapone.

    In plain wordsIn people with Addison's disease, the ACTH response to hexarelin was not clearly different from healthy people given hexarelin after metyrapone.

    Peptide
    Hexarelin
    Outcome
    No significant changeACTH response to hexarelin in Addison's disease versus normal subjects after hexarelin plus metyrapone
    Study

    n = 14

    Comparator
    Normal subjects given hexarelin after metyrapone
    Outcome group
    Stress hormones · Endocrine and hormones

    Source sentences

    Summary
    In AD, HEX elicited a marked ACTH response (6,619.4 +/- 3,365.8 pg/ml/h; p < 0.01), which was clearly higher (p < 0.01) than that in NS after HEX alone but not significantly different from that after HEX+MET.
    2 context sentences
    Summary · context
    The endocrine responses (mean +/- SEM) to HEX alone were also studied in 8 patients with Addison's disease (AD, 6 males, 2 females, age 30-77 years; last hydrocortisone administration the day before testing).
    Summary · context
    Based on the foregoing, we studied the ACTH, cortisol and GH responses to HEX (2.0 microgram/kg i.v. at 0 min) alone and after metyrapone (2 g p.o. at 23:00 h the night before) or RU-486 (400 mg p.o. at 02:00 h), a glucocorticoid receptor antagonist, in 6 normal women (NS, age 26-34 years).

    In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Hexarelin.

  2. 07HumanNot a test of Hexarelin aloneNon-randomized trialActivity measurement

    In normal women, metyrapone pretreatment increased the ACTH response to hexarelin compared with hexarelin alone.

    In plain wordsIn healthy women, the ACTH response to hexarelin was larger after metyrapone than with hexarelin alone.

    Peptide
    Hexarelin
    Outcome
    IncreaseACTH response to hexarelin after metyrapone
    Study

    n = 6

    Comparator
    Hexarelin alone
    Outcome group
    Stress hormones · Endocrine and hormones

    Source sentences

    Summary
    After metyrapone pretreatment the ACTH response to HEX was clearly increased (DeltaAUC: 2,857.4 +/- 901.9 vs. 367.3 +/- 274.0 pg/ml/h, p < 0.05), while the GH response was not modified.
    1 context sentence
    Summary · context
    Based on the foregoing, we studied the ACTH, cortisol and GH responses to HEX (2.0 microgram/kg i.v. at 0 min) alone and after metyrapone (2 g p.o. at 23:00 h the night before) or RU-486 (400 mg p.o. at 02:00 h), a glucocorticoid receptor antagonist, in 6 normal women (NS, age 26-34 years).

    In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Hexarelin.

  3. 08HumanNot a test of Hexarelin aloneNon-randomized trialActivity measurement

    In normal women, metyrapone pretreatment did not modify the GH response to hexarelin.

    In plain wordsIn healthy women, metyrapone did not change the growth hormone response to hexarelin.

    Peptide
    Hexarelin
    Outcome
    No significant changeGH response to hexarelin after metyrapone
    Study

    n = 6

    Comparator
    Hexarelin alone
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones

    Source sentences

    Summary
    After metyrapone pretreatment the ACTH response to HEX was clearly increased (DeltaAUC: 2,857.4 +/- 901.9 vs. 367.3 +/- 274.0 pg/ml/h, p < 0.05), while the GH response was not modified.
    1 context sentence
    Summary · context
    Based on the foregoing, we studied the ACTH, cortisol and GH responses to HEX (2.0 microgram/kg i.v. at 0 min) alone and after metyrapone (2 g p.o. at 23:00 h the night before) or RU-486 (400 mg p.o. at 02:00 h), a glucocorticoid receptor antagonist, in 6 normal women (NS, age 26-34 years).

    In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Hexarelin.

  4. 09HumanNot a test of Hexarelin aloneNon-randomized trialActivity measurement

    In normal women, hexarelin did not stimulate the low cortisol levels after metyrapone pretreatment.

    In plain wordsIn healthy women, hexarelin did not raise cortisol that metyrapone had pushed low.

    Peptide
    Hexarelin
    Outcome
    No significant changeCortisol response to hexarelin after metyrapone
    Study

    n = 6

    Comparator
    Basal levels
    Outcome group
    Stress hormones · Endocrine and hormones

    Source sentences

    Summary
    HEX did not stimulate the low cortisol levels after metyrapone pretreatment.
    1 context sentence
    Summary · context
    Based on the foregoing, we studied the ACTH, cortisol and GH responses to HEX (2.0 microgram/kg i.v. at 0 min) alone and after metyrapone (2 g p.o. at 23:00 h the night before) or RU-486 (400 mg p.o. at 02:00 h), a glucocorticoid receptor antagonist, in 6 normal women (NS, age 26-34 years).

    In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Hexarelin.

  5. 10HumanNot a test of Hexarelin aloneNon-randomized trialActivity measurement

    In normal women, RU-486 pretreatment did not modify the ACTH response to hexarelin.

    In plain wordsIn healthy women, RU-486 did not change the ACTH response to hexarelin.

    Peptide
    Hexarelin
    Outcome
    No significant changeACTH response to hexarelin after RU-486
    Study

    n = 6

    Comparator
    Hexarelin alone
    Outcome group
    Stress hormones · Endocrine and hormones

    Source sentences

    Summary
    RU-486 pretreatment did not modify the ACTH, cortisol and GH responses to HEX.
    1 context sentence
    Summary · context
    Based on the foregoing, we studied the ACTH, cortisol and GH responses to HEX (2.0 microgram/kg i.v. at 0 min) alone and after metyrapone (2 g p.o. at 23:00 h the night before) or RU-486 (400 mg p.o. at 02:00 h), a glucocorticoid receptor antagonist, in 6 normal women (NS, age 26-34 years).

    In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Hexarelin.

  6. 11HumanNot a test of Hexarelin aloneNon-randomized trialActivity measurement

    In normal women, RU-486 pretreatment did not modify the cortisol response to hexarelin.

    In plain wordsIn healthy women, RU-486 did not change the cortisol response to hexarelin.

    Peptide
    Hexarelin
    Outcome
    No significant changeCortisol response to hexarelin after RU-486
    Study

    n = 6

    Comparator
    Hexarelin alone
    Outcome group
    Stress hormones · Endocrine and hormones

    Source sentences

    Summary
    RU-486 pretreatment did not modify the ACTH, cortisol and GH responses to HEX.
    1 context sentence
    Summary · context
    Based on the foregoing, we studied the ACTH, cortisol and GH responses to HEX (2.0 microgram/kg i.v. at 0 min) alone and after metyrapone (2 g p.o. at 23:00 h the night before) or RU-486 (400 mg p.o. at 02:00 h), a glucocorticoid receptor antagonist, in 6 normal women (NS, age 26-34 years).

    In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Hexarelin.

  7. 12HumanNot a test of Hexarelin aloneNon-randomized trialActivity measurement

    In normal women, RU-486 pretreatment did not modify the GH response to hexarelin.

    In plain wordsIn healthy women, RU-486 did not change the growth hormone response to hexarelin.

    Peptide
    Hexarelin
    Outcome
    No significant changeGH response to hexarelin after RU-486
    Study

    n = 6

    Comparator
    Hexarelin alone
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones

    Source sentences

    Summary
    RU-486 pretreatment did not modify the ACTH, cortisol and GH responses to HEX.
    1 context sentence
    Summary · context
    Based on the foregoing, we studied the ACTH, cortisol and GH responses to HEX (2.0 microgram/kg i.v. at 0 min) alone and after metyrapone (2 g p.o. at 23:00 h the night before) or RU-486 (400 mg p.o. at 02:00 h), a glucocorticoid receptor antagonist, in 6 normal women (NS, age 26-34 years).

    In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Hexarelin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.